ebselen has been researched along with atractyloside in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boireau, A; Dubédat, P; Maréchal, PM; Meunier, M; Moussaoui, S | 1 |
| Buelna-Chontal, M; Chávez, E; Correa, F; Hernández-Esquivel, L; Pavón, N | 1 |
2 other study(ies) available for ebselen and atractyloside
| Article | Year |
|---|---|
The anti-oxidant ebselen antagonizes the release of the apoptogenic factor cytochrome c induced by Fe2+/citrate in rat liver mitochondria.
Topics: Animals; Antioxidants; Apoptosis; Atractyloside; Azoles; Citrates; Cytochrome c Group; Ferrous Compounds; Intracellular Membranes; Isoindoles; Male; Mitochondria, Liver; Organoselenium Compounds; Permeability; Rats; Rats, Sprague-Dawley; Spectrophotometry | 2000 |
Ebselen induces mitochondrial permeability transition because of its interaction with adenine nucleotide translocase.
Topics: Animals; Antioxidants; Atractyloside; Azoles; Calcium; Isoindoles; Mitochondria; Mitochondrial ADP, ATP Translocases; Mitochondrial Swelling; Organoselenium Compounds; Permeability; Rats | 2015 |